ID1 and neoplasm: Taken together, these experiments suggest that the lack of Id1 expression in both tumor cells and the tumor microenvironment, along with the blockade of PD-1/PD-L1 axis, exerts the most potent antitumor effect in murine KRAS-driven LUAD (Figure 3F).